Steven Leventer, Ph.D. has been appointed vice president, Clinical Research Neuroscience at PharmaNet Development Group, Inc. Dr. Leventer has more than 20 years of experience in all phases of drug development. He has spent most of his career leading clinical teams at large global pharmaceutical and contract research organizations in the development of therapeutics for Alzheimer’s disease, schizophrenia, depression and other central nervous system diseases.

“We are very pleased to have Steve join PharmaNet Development Group,” commented Dalvir Gill, chief operating officer, Late Stage Development at PharmaNet. “Steve is a recognized expert in the fields of clinical trial design and clinical development planning. His combination of neuroscience expertise and dedication to efficiency and quality provides the right complement to our existing organization.”